Sun Pharma Advanced Research Company Ltd., incorporated in the year 2006, is a Mid Cap company (having a market cap of Rs 8462.08 Crore) operating in Pharmaceuticals sector.
Sun Pharma Advanced Research Company Ltd. key Products/Revenue Segments include Sale of services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-09-2021, the company reported a Standalone Total Income of Rs 33.85 Crore, up 48.53 % from last quarter Total Income of Rs 22.79 Crore and up 65.44 % from last year same quarter Total Income of Rs 20.46 Crore. Company reported net profit after tax of Rs -55.14 Crore in latest quarter.
Investment Rationale
The stock is on the verge of a breakout from a bullish Flag pattern suggesting bullishness building up. A sustained trade above Rs 334 will take it higher to levels of Rs 345. RSI is also suggesting the same.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.